ASP Isotopes Inc. (ASPI)
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
Sector: Miscellaneous Chemical Products
Industry: Chemicals - Specialty
ASP Isotopes Inc. Common Stock
NASDAQ:ASPIBasic Materials · Chemicals - Specialty
-10.71%$1.38
Prev close$1.540.00%Open$1.54-10.71%Now$1.38
Mkt Cap$214.27M
EV-
Float122.67M
O/S155.83M
VOL3.21M sh
$ Vol$4.56M
RVOL0.84×
Inst Own40.5%
SI25.6%
Net Cash/Sh-
Dilution
MCap$214.27MFloat122.67MO/S155.83M
Dilution
1-25 of 410 filings
…
Recent SEC filings with analysis
- 10-QASP Isotopes filed its Q3 2026 10-Q showing revenue of $5.1 million for the quarter, up roughly 4x from $1.3 million a year ago, driven by the January 2026…
- SCHEDULE 13DASP Isotopes and its wholly owned subsidiary LHE LNG Holdings filed a Schedule 13D disclosing beneficial ownership of 254,015 ENDRA Life Sciences common…